EichorEICHOR
Study identifier: NCT07332455 Synced from ClinicalTrials.gov · August 07, 2026
● Study status: Recruiting

First-Time-in-Human Study of GSK5471713 in Adults With mCRPC

Condition: Neoplasms, Prostate  ·  Sponsor: GlaxoSmithKline

PhasePhase 1/Phase 2
Planned participants54
Who can joinMale, 18 Years to no upper limit
Healthy volunteersNo

Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.

About this study

This first-time-in-human study will evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, preliminary clinical activity, and establish the benefit/risk of GSK5471713 given as a monotherapy in mCRPC.

This description comes directly from the study's public registry record.

Talk to the study team

US GSK Clinical Trials Call Center  ·  877-379-3718  ·  GSKClinicalSupportHD@gsk.com

EU GSK Clinical Trials Call Center  ·  +44 (0) 20 89904466  ·  GSKClinicalSupportHD@gsk.com

Always discuss trial participation with your own doctor first.

Locations (11)

GSK Investigational SiteLa Jolla, California, United StatesRecruiting
GSK Investigational SiteGrand Rapids, Michigan, United StatesRecruiting
GSK Investigational SitePhiladelphia, Pennsylvania, United StatesRecruiting
GSK Investigational SiteWest Valley City, Utah, United StatesRecruiting
GSK Investigational SiteMelbourne, Victoria, AustraliaRecruiting
GSK Investigational SiteToronto, Ontario, CanadaRecruiting
GSK Investigational SiteMontreal, Quebec, CanadaRecruiting
GSK Investigational SiteTokyo, JapanRecruiting
GSK Investigational SiteTokyo, JapanRecruiting
GSK Investigational SiteSeoul, Seoul Teugbyeolsi, South KoreaRecruiting
GSK Investigational SiteSeoul, South KoreaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Look up another condition
Look up another city
Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →